{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-026154","form_type":"8-K","ticker":"ZVRA","cik":"0001434647","company_name":"ZEVRA THERAPEUTICS, INC.","filed_at":"2021-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.575615+00:00","generated_at":"2026-06-28T09:48:58.572619+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"KemPharm Q3 net loss $0.05/sh; appoints Richard Pascoe as Executive Chairman","bullets":["Q3 2021 net loss $1.8M ($0.05 per basic share); revenue $2.0M (mostly service fees).","Cash and equivalents $131.5M at Sep 30, 2021; 35.3M shares outstanding basic.","Richard W. Pascoe appointed Executive Chairman, effective Nov 10, 2021.","Pascoe receives $400K base salary, option for 100K shares with performance vesting.","AZSTARYS commercial launch initiated Jul 21; >50M lives now have access per Corium."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-026154","json":"https://secwatch.observer/filing/0001437749-21-026154.json","markdown":"https://secwatch.observer/filing/0001437749-21-026154.md","text":"https://secwatch.observer/filing/0001437749-21-026154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434647/000143774921026154/0001437749-21-026154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434647/000143774921026154/kmph20210921_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T09:48:58.572619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"33fa387445","claim":"Richard W. Pascoe was appointed as Executive Chairman at ZEVRA THERAPEUTICS, INC..","evidence_excerpt":"On November 5, 2021, the Board of Directors of KemPharm appointed Richard W. Pascoe as KemPharm’s Executive Chairman.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774921026154/0001437749-21-026154-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}